Brenntag, the global market leader in chemicals and ingredients distribution, and American global food corporation Cargill, have entered into an exclusive distribution agreement for EpiCor postbiotic. The agreement covers most parts of Europe including UK, Ireland, Italy, Spain, Portugal, France, BeNeLux, the DACH region, CEE including Baltics and Ukraine, Norway, Sweden, Denmark, Finland and Iceland.

EpiCor is a postbiotic ingredient derived from the proprietary fermentation of baker’s yeast (Saccharomyces cerevisiae). The end result is a nutritious whole food with metabolites including proteins, vitamins, minerals, antioxidants and polyphenols, fibers and polysaccharides, and other nutrients.

EpiCor also meets to the newly released consensus definition of a postbiotic, as put forth by the International Scientific Association for Probiotics and Prebiotics (ISAPP). EpiCor is a preparation of inanimate microorganisms and components that may support immune and gut health functions, as substantiated in over a dozen published studies.

Frank Haven, president Brenntag Specialties Nutrition EMEA, says, “We are delighted to increase the scope of our alliance with Cargill on exclusive basis for EpiCor, a leading postbiotic nutrition and dietary product. To the very important and intensely growing Nutritional Health, we bring the knowledge, infrastructure and creative innovation capabilities of Brenntag's Food and Nutrition team together with the overarching expertise of Cargill."

Willem van Dam, director Industry Market Management Brenntag Specialties Nutrition EMEA, adds, “We look forward to developing and broadening relationships with our existing and new customers with this new offer of EpiCor. This will meet the current needs of our customers as well as new product requirements and can generate new product development projects.”